AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇬🇭

Abacavir Sulfate/Dolutegravir Sodium/Lamivudine in Ghana

14 products registered with FDA Ghana — 14 active

Brand / ProductReg. No.HolderStatusExpires
FDA/SD.255-111995UNKNOWN-91e9d892—active31 Dec 2030
KAVIDEZA DISTAB TABLETS (Each dispersible tablet contains Abacavir Sulfate/Dolutegravir Sodium/Lamivudine 60mg/5mg/30mg)UNKNOWN-418b82dd—active31 Dec 2030
FDA/SD.255-111995UNKNOWN-6411b626—active31 Dec 2030
KAVIDEZA DISTAB TABLETS (Each dispersible tablet contains Abacavir Sulfate/Dolutegravir Sodium/Lamivudine 60mg/5mg/30mg)UNKNOWN-e300b094—active31 Dec 2030
ABLADO DT TABLETSUNKNOWN-d31a0183—active1 Aug 2030
ABLADO DT TABLETSUNKNOWN-984fccfc—active1 Aug 2030
ABLADO TABLETSUNKNOWN-a6de668a—active1 Aug 2030
ABLADO TABLETSUNKNOWN-5a53731d—active1 Aug 2030
ABACAVIR_DOLUTEGRAVIR_LAMIVUDINE​ ​TABLETSUNKNOWN-9c2e9a08—active1 Jul 2030
ABACAVIR_DOLUTEGRAVIR_LAMIVUDINE​ ​TABLETSUNKNOWN-08485be8—active1 Jul 2030
ABACAVIR/DOLUTEGRAVIR/LAMIVUDINE ​TABLETSUNKNOWN-fa3e9f41—active1 Dec 2028
ABACAVIR/DOLUTEGRAVIR/LAMIVUDINE ​TABLETSUNKNOWN-a49c4d2d—active1 Dec 2028
ABACAVIR/DOLUTEGRAVIR/LAMIVUDINE TABLETS FOR ORAL SUSPENSION (Each tablet contains: Abacavir Sulfate/Dolutegravir Sodium/Lamivudine 60mg/5mg/30mg)UNKNOWN-8a4ce9c0—active1 Feb 2027
ABACAVIR/DOLUTEGRAVIR/LAMIVUDINE TABLETS FOR ORAL SUSPENSION (Each tablet contains: Abacavir Sulfate/Dolutegravir Sodium/Lamivudine 60mg/5mg/30mg)UNKNOWN-5ceb88db—active1 Feb 2027

Abacavir Sulfate/Dolutegravir Sodium/Lamivudine — FDA Ghana Registration Details

FDA Ghana (Ghana) has 14 registered products containing Abacavir Sulfate/Dolutegravir Sodium/Lamivudine, of which 14 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.

Track Abacavir Sulfate/Dolutegravir Sodium/Lamivudine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.